At a glance
- Originator Zenyaku Kogyo
- Mechanism of Action Choline acetyltransferase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Japan
- 08 Feb 2002 Preclinical development for Cognition disorders in Japan (Unknown route)